CD274 and neoplasm: Similar outcomes were also observed for GL261 GBM tumor–bearing mice (20.5 days for PD-L1 mAb mice vs. 45.5 days for PD-L1 mAb + oeTRAF3 mice) (Supplemental Figure 8M).